27Jun

Forté Pharma strengthens its leadership in weight control in France

21Jun

Start of coverage through three equity research reports

14Jun

Scrip dividend: beginning of the trading period of the allotment rights

07Jun

Remuneration through the scrip dividend or flexible dividend

08May

Results note: First quarter 2018

03May

Resolutions on the general shareholders' meeting

09Apr

Investment plan to expand the injectable products plant of Barcelona

23Mar

Convening of the Ordinary and Extraordinary General Shareholders’ Meeting

23Mar

Reig Jofre and Leanbio create the joint venture Syna Therapeutics for the development of biosimilar products